Should You Buy Endocyte, Inc (NASDAQ: ECYT) at $14.29?
Shares of Endocyte, Inc (NASDAQ: ECYT) are receiving a lot of investor interest as of late due to the stock’s 300.3% increase over the prior three months. Shareholders are now asking themselves whether the company’s current stock price is reflective of its true value or if shares have even further upside from here. Let’s take a look… Keep Reading